METTLER TOLEDO INTERNATIONAL INC/
MTDHealthcaremt.com
Latest available resultsJune 30, 2026Quarter · 10-Q filed Jul 31, 2026
Results announcedNovember 5, 2026EPS vs forecast ▲ +2.9%Detailed filing pending
Next reportFebruary 3, 2027after close · forecast 15.031 $/share
Revenue
$1.03B
▲ +4.5% vs prior year YoY
Net income
$232.90M
▲ +15.1% vs prior year YoY
EPS
11.55$
▲ +18.3% vs prior year YoY
Net margin
22.7%
▲ +2.1 pp vs prior year YoY
Revenue▲ +4.5%
Margins (% of revenue)GrossOperating N/ANet
Net income▲ +15.1%
EPS▲ +18.3%
Financial statements
View 10-Q filed July 31, 2026 on SEC ↗| Metric | Sep 2024 | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $954.53M | $1.05B | $883.74M | $983.22M | $1.03B | $1.13B | $947.13M | $1.03B | ▲ +4.5% |
| Gross profit | $572.47M | $639.32M | $525.88M | $579.88M | $609.46M | $675.43M | $555.82M | $650.22M | ▲ +12.1% |
| Operating incomenever filed | — | — | — | — | — | — | — | — | — |
| Net income | $211.52M | $252.30M | $163.59M | $202.35M | $217.49M | $285.76M | $169.45M | $232.90M | ▲ +15.1% |
| R&D | $47.12M | $50.05M | $46.35M | $49.28M | $51.14M | $52.60M | $51.27M | $52.99M | ▲ +7.5% |
| EPS (diluted) | 9.96 $ | — | 7.81 $ | 9.76 $ | 10.57 $ | — | 8.33 $ | 11.55 $ | ▲ +18.3% |
| Margins (% of revenue) | |||||||||
| Gross | 60.0 % | 61.2 % | 59.5 % | 59.0 % | 59.2 % | 59.8 % | 58.7 % | 63.3 % | ▲ +4.3 pt |
| Operating | — | — | — | — | — | — | — | — | — |
| Net | 22.2 % | 24.1 % | 18.5 % | 20.6 % | 21.1 % | 25.3 % | 17.9 % | 22.7 % | ▲ +2.1 pt |
| Balance sheet | |||||||||
| Assets | $3.32B | $3.24B | $3.23B | $3.40B | $3.52B | $3.71B | $3.67B | $3.67B | ▲ +8.0% |
| Liabilities | $3.47B | $3.37B | $3.42B | $3.66B | $3.77B | $3.74B | $3.71B | $3.66B | ▼ -0.0% |
| Equity | −$154.35M | −$126.89M | −$181.98M | −$258.79M | −$249.20M | −$23.64M | −$41.88M | $12.82M | ▲ +105.0% |
| Cash | $71.57M | $59.36M | — | $61.83M | $69.06M | $66.89M | — | $51.38M | ▼ -16.9% |
| Capital | |||||||||
| Shares outstanding | — | 20.92M | — | — | 20.43M | 20.33M | 20.21M | — | — |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.